Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
10,667,865
-
Shares change
-
-240,434
-
Total reported value, excl. options
-
$108,909,000
-
Value change
-
-$2,638,131
-
Number of buys
-
9
-
Number of sells
-
-12
-
Price
-
$10.20
Significant Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) as of Q1 2021
49 filings reported holding HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM as of Q1 2021.
MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,667,865 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (1,011,589 shares), PRICE T ROWE ASSOCIATES INC /MD/ (792,285 shares), BlackRock Inc. (750,153 shares), RTW INVESTMENTS, LP (750,000 shares), RA CAPITAL MANAGEMENT, L.P. (700,000 shares), CITADEL ADVISORS LLC (693,367 shares), WELLINGTON MANAGEMENT GROUP LLP (526,725 shares), Ghost Tree Capital, LLC (500,000 shares), Cormorant Asset Management, LP (430,000 shares), and Octagon Capital Advisors LP (400,000 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.